Hypoxia in head and neck cancerCitation formats

  • Authors:
  • A. Y. Isa
  • T. H. Ward
  • C. M L West
  • N. J. Slevin
  • J. J. Homer

Standard

Hypoxia in head and neck cancer. / Isa, A. Y.; Ward, T. H.; West, C. M L; Slevin, N. J.; Homer, J. J.

In: British Journal of Radiology, Vol. 79, No. 946, 10.2006, p. 791-798.

Research output: Contribution to journalArticlepeer-review

Harvard

Isa, AY, Ward, TH, West, CML, Slevin, NJ & Homer, JJ 2006, 'Hypoxia in head and neck cancer', British Journal of Radiology, vol. 79, no. 946, pp. 791-798. https://doi.org/10.1259/bjr/17904358

APA

Isa, A. Y., Ward, T. H., West, C. M. L., Slevin, N. J., & Homer, J. J. (2006). Hypoxia in head and neck cancer. British Journal of Radiology, 79(946), 791-798. https://doi.org/10.1259/bjr/17904358

Vancouver

Isa AY, Ward TH, West CML, Slevin NJ, Homer JJ. Hypoxia in head and neck cancer. British Journal of Radiology. 2006 Oct;79(946):791-798. https://doi.org/10.1259/bjr/17904358

Author

Isa, A. Y. ; Ward, T. H. ; West, C. M L ; Slevin, N. J. ; Homer, J. J. / Hypoxia in head and neck cancer. In: British Journal of Radiology. 2006 ; Vol. 79, No. 946. pp. 791-798.

Bibtex

@article{83656f647f9d443aa2ea91d53379e252,
title = "Hypoxia in head and neck cancer",
abstract = "A high level of hypoxia in solid tumours is an adverse prognostic factor for the poor outcome of cancer patients following treatment. This review describes the status of research into finding a practical method for measuring hypoxia and treating hypoxic tumours. The application of such methodology would enable the selection of head and neck cancer treatment based on an individual's tumour oxygenation status. This individualization would include the selection not only of surgery or radiotherapy, but also of novel hypoxia-modification strategies. {\textcopyright} 2006 The British Institute of Radiology.",
keywords = "therapeutic use: Antibiotics, Antineoplastic, analysis: Basic Helix-Loop-Helix Transcription Factors, analysis: Biological Markers, Cell Hypoxia, Comet Assay, blood supply: Head and Neck Neoplasms, metabolism: Hemoglobins, Humans, analysis: Hypoxia-Inducible Factor 1, alpha Subunit, Microelectrodes, diagnostic use: Nitroimidazoles, administration & dosage: Oxygen, methods: Positron-Emission Tomography, Prognosis, therapeutic use: Radiation-Sensitizing Agents",
author = "Isa, {A. Y.} and Ward, {T. H.} and West, {C. M L} and Slevin, {N. J.} and Homer, {J. J.}",
year = "2006",
month = oct,
doi = "10.1259/bjr/17904358",
language = "English",
volume = "79",
pages = "791--798",
journal = "British Journal of Radiology",
issn = "0007-1285",
publisher = "British Institute of Radiology",
number = "946",

}

RIS

TY - JOUR

T1 - Hypoxia in head and neck cancer

AU - Isa, A. Y.

AU - Ward, T. H.

AU - West, C. M L

AU - Slevin, N. J.

AU - Homer, J. J.

PY - 2006/10

Y1 - 2006/10

N2 - A high level of hypoxia in solid tumours is an adverse prognostic factor for the poor outcome of cancer patients following treatment. This review describes the status of research into finding a practical method for measuring hypoxia and treating hypoxic tumours. The application of such methodology would enable the selection of head and neck cancer treatment based on an individual's tumour oxygenation status. This individualization would include the selection not only of surgery or radiotherapy, but also of novel hypoxia-modification strategies. © 2006 The British Institute of Radiology.

AB - A high level of hypoxia in solid tumours is an adverse prognostic factor for the poor outcome of cancer patients following treatment. This review describes the status of research into finding a practical method for measuring hypoxia and treating hypoxic tumours. The application of such methodology would enable the selection of head and neck cancer treatment based on an individual's tumour oxygenation status. This individualization would include the selection not only of surgery or radiotherapy, but also of novel hypoxia-modification strategies. © 2006 The British Institute of Radiology.

KW - therapeutic use: Antibiotics, Antineoplastic

KW - analysis: Basic Helix-Loop-Helix Transcription Factors

KW - analysis: Biological Markers

KW - Cell Hypoxia

KW - Comet Assay

KW - blood supply: Head and Neck Neoplasms

KW - metabolism: Hemoglobins

KW - Humans

KW - analysis: Hypoxia-Inducible Factor 1, alpha Subunit

KW - Microelectrodes

KW - diagnostic use: Nitroimidazoles

KW - administration & dosage: Oxygen

KW - methods: Positron-Emission Tomography

KW - Prognosis

KW - therapeutic use: Radiation-Sensitizing Agents

U2 - 10.1259/bjr/17904358

DO - 10.1259/bjr/17904358

M3 - Article

VL - 79

SP - 791

EP - 798

JO - British Journal of Radiology

JF - British Journal of Radiology

SN - 0007-1285

IS - 946

ER -